<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>302(20)</volume><submitter>Kent DM</submitter><funding>NCRR NIH HHS</funding><journal>JAMA</journal><pagination>2254-6</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC3063072</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Therapeutic innovations, diminishing returns, and control rate preservation.</pubmed_title><pmcid>PMC3063072</pmcid><funding_grant_id>UL1 RR025752</funding_grant_id><funding_grant_id>UL1 RR025752-015980</funding_grant_id><funding_grant_id>UL1 RR025752-027213</funding_grant_id><pubmed_authors>Trikalinos TA</pubmed_authors><pubmed_authors>Kent DM</pubmed_authors></additional><is_claimable>false</is_claimable><name>Therapeutic innovations, diminishing returns, and control rate preservation.</name><description/><dates><release>2009-01-01T00:00:00Z</release><publication>2009 Nov</publication><modification>2025-04-05T00:26:37.491Z</modification><creation>2025-04-05T00:26:37.491Z</creation></dates><accession>S-EPMC3063072</accession><cross_references><pubmed>19934428</pubmed><doi>10.1001/jama.2009.1679</doi></cross_references></HashMap>